New obesity treatment may help preserve muscle during weight loss

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG. Fox News correspondent Alexandria Hoff reports on the safety and legality of peptides, found in GLP-1 weight loss drugs, on ‘Special Report.’ During a recent episode of her podcast, Gwyneth Paltrow spoke with neuroscientist Dr. Andrew Huberman about retatrutide, a new advancement in GLP-1 (glucagon-like peptide-1) therapies. In recent years, GLP-1 receptor agonists have become a major focus in discussions around biohacking, longevity and wellness – but they’re not without a multitude of side effects. Huberman noted that while first-generation weight-loss drugs curbed users' appetites, they frequently plunged them into massive, rapid caloric deficits. 'NEXT OZEMPIC' AIMS TO DELIVER 30% WEIGHT LOSS WITH FEWER SIDE EFFECTS Without aggressive resistance training, a high percentage of that lost weight came directly from lean muscle. "People would lose a t